Have a personal or library account? Click to login
Quantitative analysis and pharmacokinetic study of a novel diarylurea EGFR inhibitor (ZCJ14) in rat plasma using a validated LC-MS/MS method Cover

Quantitative analysis and pharmacokinetic study of a novel diarylurea EGFR inhibitor (ZCJ14) in rat plasma using a validated LC-MS/MS method

Acta Pharmaceutica
Volume 71 (2021): Issue 3 (September 2021)
By: Sai-Jie Zuo,  Xiao-Liang Cheng,  Dong-Zheng Liu,  Wei-Yi Feng,  Yong-Xiao Cao and  San-Qi Zhang  
Open Access
|Dec 2020
DOI: https://doi.org/10.2478/acph-2021-0024 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075
Journal RSS Feed
Language: English
Page range: 415 - 428
Accepted on: Aug 4, 2020
Published on: Dec 31, 2020
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
ZCJ14,
epidermal growth factor receptor inhibitor,
LC-MS/MS,
pharmacokinetics,
bioavailability
Related subjects:
Pharmacy,
Pharmacy, other

© 2020 Sai-Jie Zuo, Xiao-Liang Cheng, Dong-Zheng Liu, Wei-Yi Feng, Yong-Xiao Cao, San-Qi Zhang, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous articleVolume 71 (2021): Issue 3 (September 2021)Next article